Summary
Anika Therapeutics Inc (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Anika Therapeutics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Anika Therapeutics Inc Company Overview 6
Anika Therapeutics Inc Company Snapshot 6
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Anika Therapeutics Inc – Pipeline Analysis Overview 9
Business Description 9
Anika Therapeutics Inc - Key Facts 9
Anika Therapeutics Inc - Major Products and Services 11
Anika Therapeutics Inc Pipeline Products by Development Stage 13
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 15
Anika Therapeutics Inc Pipeline Products Overview 17
Cingal 17
Cingal Product Overview 17
Cronofill 18
Cronofill Product Overview 18
Hemostatic Patch 19
Hemostatic Patch Product Overview 19
HYAFF Barrier Film 20
HYAFF Barrier Film Product Overview 20
HYAFF Gel 21
HYAFF Gel Product Overview 21
HYAFF Mesh 22
HYAFF Mesh Product Overview 22
HYAFF/ACP Spray - Adhesion 23
HYAFF/ACP Spray - Adhesion Product Overview 23
Hyalobone 24
Hyalobone Product Overview 24
Hyalofast 25
Hyalofast Product Overview 25
Hyalofast Clinical Trial 26
Hyaloglide 27
Hyaloglide Product Overview 27
Hyalograft C Autograft 28
Hyalograft C Autograft Product Overview 28
Hyalonect 29
Hyalonect Product Overview 29
MONOVISC 30
MONOVISC Product Overview 30
MONOVISC - Hip 31
MONOVISC - Hip Product Overview 31
MONOVISC - Hip Clinical Trial 32
Next Generation ELEVESS Dermal Filler 33
Next Generation ELEVESS Dermal Filler Product Overview 33
ORTHOVISC-T 34
ORTHOVISC-T Product Overview 34
Anika Therapeutics Inc - Key Competitors 35
Anika Therapeutics Inc - Key Employees 36
Anika Therapeutics Inc - Key Employee Biographies 37
Anika Therapeutics Inc - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Anika Therapeutics Inc, Recent Developments 39
Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 39
Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 40
Dec 19, 2016: Anika Wins CE Mark Approval For ORTHOVISC-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury 41
Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 41
Sep 22, 2016: Anika Announces Data Presentations on HYALOFAST Hyaluronic Acid-Based Scaffold at 2016 World Congress of the International Cartilage Repair Society 42
Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results 42
Jun 01, 2016: Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis 43
May 19, 2016: Pendopharm Announces Canadian Launch Of Cingal In Partnership With Anika Therapeutics 43
Apr 27, 2016: Anika Reports First Quarter 2016 Financial Results 44
Apr 04, 2016: Anika Appoints New Chief Medical Officer and Chief Operations Officer 45
Appendix 46
Methodology 46
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Tables
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Anika Therapeutics Inc Pipeline Products by Equipment Type 7
Anika Therapeutics Inc Pipeline Products by Indication 8
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 8
Anika Therapeutics Inc, Key Facts 9
Anika Therapeutics Inc, Major Products and Services 11
Anika Therapeutics Inc Number of Pipeline Products by Development Stage 13
Anika Therapeutics Inc Pipeline Products Summary by Development Stage 14
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 15
Anika Therapeutics Inc Ongoing Clinical Trials Summary 16
Cingal - Product Status 17
Cingal - Product Description 17
Cronofill - Product Status 18
Cronofill - Product Description 18
Hemostatic Patch - Product Status 19
Hemostatic Patch - Product Description 19
HYAFF Barrier Film - Product Status 20
HYAFF Barrier Film - Product Description 20
HYAFF Gel - Product Status 21
HYAFF Gel - Product Description 21
HYAFF Mesh - Product Status 22
HYAFF Mesh - Product Description 22
HYAFF/ACP Spray - Adhesion - Product Status 23
HYAFF/ACP Spray - Adhesion - Product Description 23
Hyalobone - Product Status 24
Hyalobone - Product Description 24
Hyalofast - Product Status 25
Hyalofast - Product Description 25
Hyalofast - A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control 26
Hyaloglide - Product Status 27
Hyaloglide - Product Description 27
Hyalograft C Autograft - Product Status 28
Hyalograft C Autograft - Product Description 28
Hyalonect - Product Status 29
Hyalonect - Product Description 29
MONOVISC - Product Status 30
MONOVISC - Product Description 30
MONOVISC - Hip - Product Status 31
MONOVISC - Hip - Product Description 31
MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip 32
Next Generation ELEVESS Dermal Filler - Product Status 33
Next Generation ELEVESS Dermal Filler - Product Description 33
ORTHOVISC-T - Product Status 34
ORTHOVISC-T - Product Description 34
Anika Therapeutics Inc, Key Employees 36
Anika Therapeutics Inc, Key Employee Biographies 37
Anika Therapeutics Inc, Subsidiaries 38
Glossary 47
List of Figures
Anika Therapeutics Inc Pipeline Products by Equipment Type 7
Anika Therapeutics Inc Pipeline Products by Development Stage 13
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 15
